SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-21-151822
Filing Date
2021-12-20
Accepted
2021-12-20 17:48:22
Documents
1
Period of Report
2021-12-20

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2135965-2_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2135965-2_4seq1.xml 4 6516
  Complete submission text file 0001104659-21-151822.txt   8199
Mailing Address PO BOX 13628 68 TW ALEXANDER DRIVE RESEARCH TRIANGLE PARK NC 27709
Business Address PO BOX 13628 68 TW ALEXANDER DRIVE RESEARCH TRIANGLE PARK NC 27709 (919) 636-4530
FENNEC PHARMACEUTICALS INC. (Issuer) CIK: 0001211583 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O ADHEREX TECHNOLOGIES INC. 4620 CREEKSTONE DRIVE, SUITE 200 DURHAM NC 27703
Business Address
Andrade Robert (Reporting) CIK: 0001468308 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-32295 | Film No.: 211506279